Trial · NCT07136844
Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
NCT07136844, Not applicable, Recruiting, Centre Hospitalier Universitaire de Liege
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology. Trials, record NCT07136844. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07136844
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
- NCT number
- NCT07136844
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 300 participants, estimated
- Lead sponsor
- Centre Hospitalier Universitaire de Liege
- Conditions
Neuromuscular Diseases, Obesity (Disorder), Myotonic Dystrophy 1, Myasthenic Syndrome, Charcot Marie Tooth Disease (CMT), Glycogen Storage Disease Type II Pompe Disease, Facio-Scapulo-Humeral Dystrophy, Myasthenia Gravis, Huntington Disease, Progressive Supranuclear Palsy (PSP), Hereditary Spastic Paraplegia, Ataxia, Spinocerebellar
- Interventions
Syde, Dynamometric measurements of muscle strength, The 6-minute walk test (6MWT), The 10-meter test (10MWT), The 4 stair-climbing test (4SC), Test of rising from the floor (TRF), The Timed up and go test (TUG), The Progressive Supranuclear Palsy Rating Scale (PSP-RS), The Montreal Cognitive Assessment (MOCA), The Charcot-Marie-Tooth examination score (CMTES), 9-Hole Peg Test (9-HPT), The Unified Huntington's Disease Rating Scale (UHDRS), Quantitative Myasthenia Gravis (QMG), The Myasthenia Gravis Activities of Daily Living Scale (MG-ADL), The Scale for the Assessment and Rating of Ataxia (SARA), Patient's Global Impression of Change (PGIC)
- First posted
- 2025-08-22
- Last updated
- 2025-08-22
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | 95th Centile of Stride Velocity (SV95C) | Every 6 months for up to 2 years | Change in SV95C as measured by the Syde® wearable device, used to assess ambulatory function in real-life settings. |
| Secondary | Device Acceptability and Adherence | Over 2 years | Measures of user engagement with the Syde® device over time, including total recording time, valid days (≥5 hours), and time to reach 50 and 180 hours. |
| Secondary | Correlation between Syde® and 6MWT | Every 6 months for up to 2 years | Correlation between the Syde digital variable and results from the 6-minute walk test (6MWT) |
| Secondary | Correlation between Syde® and 10MWT | Every 6 months for up to 2 years | Correlation between the Syde digital variable and results from the 10-meter test (10MWT) |
| Secondary | Correlation between Syde® and 4SC | Every 6 months for up to 2 years | Correlation between the Syde digital variable and results from the 4 stair-climbing test (4SC) |
| Secondary | Correlation between Syde® and TRF | Every 6 months for up to 2 years | Correlation between the Syde digital variable and results from the test of rising from the floor (TRF) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07136844
GET https://conductscience.org/api/trials/v1/NCT07136844/registered